ArticleVaccines2021

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant.

Ruiqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.